References
- Scheinfeld N. S., Mikhail M. Common diseases/treatment options: Treatment options for psoriasis part 1: Topical treatments. Skinmed 2004; 3: 225–7
- Serup J., Blichmann C. Epidermal hydration of psoriasis plaques and the relation to scaling. Measurement of electrical conductance and transepidermal water loss. Acta Derm Venereol 1987; 67: 357–9
- Warino L., Balkrishnan R., Feldman S. R. Clobetasol propionate for psoriasis: Are ointments really more potent?. J Drugs Dermatol 2006; 5: 527–32
- Carroll C. L., Feldman S. R., Camacho F. T., Manuel J. C., Balkrishnan R. Adherence to topical therapy decreases during the course of an 8‐week psoriasis clinical trial: Commonly used methods of measuring adherence to topical therapy overestimate actual use. J Am Acad Dermatol 2004; 51: 212–16
- Jarratt M. T., Clark S. D., Savin R. C., Swinyer L. J., Safley C. F., Brodell R. T., et al. Evaluation of the efficacy and safety of clobetasol propionate spray in the treatment of plaque‐type psoriasis. Cutis 2006; 78: 348–54
- Feldman S. R., Camacho F. T., Krejci‐Manwaring J., Carroll C. L., Balkrishnan R. Adherence to topical therapy increases around the time of office visits. J Am Acad Dermatol 2007; 57: 81–3